| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |